Patents by Inventor Avner Ingerman

Avner Ingerman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENTS OF OCULAR ALLERGY WITH ALCAFTADINE
    Publication number: 20240058355
    Abstract: Compositions, kits and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof comprising alcaftadine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 28, 2023
    Publication date: February 22, 2024
    Inventors: Avner Ingerman, Frans Janssens, Anton Megens, Mark B. Abelson
  • TREATMENTS OF OCULAR ALLERGY WITH ALCAFTADINE
    Publication number: 20230181594
    Abstract: Compositions, kits and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof comprising alcaftadine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 20, 2022
    Publication date: June 15, 2023
    Inventors: Avner Ingerman, Frans Janssens, Anton Megens, Mark B. Abelson
  • TREATMENTS OF OCULAR ALLERGY WITH ALCAFTADINE
    Publication number: 20210030762
    Abstract: Compositions, kits and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof comprising alcaftadine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 11, 2020
    Publication date: February 4, 2021
    Inventors: Avner Ingerman, Frans Janssens, Anton Megens, Mark B. Abelson
  • Ophthalmic compositions containing alcaftadine
    Patent number: 10617695
    Abstract: Compositions, kits and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof containing alcaftadine or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: April 14, 2020
    Assignee: Vistakon Pharmaceuticals, LLC
    Inventors: Avner Ingerman, Frans Janssens, Anton Megens, Mark B. Abelson
  • TREATMENTS OF OCULAR ALLERGY WITH ALCAFTADINE
    Publication number: 20170065605
    Abstract: Compositions, kits and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof comprising alcaftadine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 16, 2016
    Publication date: March 9, 2017
    Inventors: Avner Ingerman, Frans Janssens, Anton Megens, Mark B. Abelson
  • Ocular Allergy Treatments
    Publication number: 20140107102
    Abstract: Compositions, kits and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof comprising alcaftadine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 8, 2013
    Publication date: April 17, 2014
    Applicant: Allergan, Inc.
    Inventors: Jagdish Parasrampuria, Avner Ingerman, Frans Janssens, Anton Megens
  • Ocular allergy treatments with alcaftadine
    Patent number: 8664215
    Abstract: Compositions, kits, and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof containing alcaftadine or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 26, 2007
    Date of Patent: March 4, 2014
    Assignee: Vistakon Pharmaceuticals, LLC
    Inventors: Avner Ingerman, Frans Janssens, Anton Megens, Mark B. Abelson
  • Ocular Allergy Treatments
    Publication number: 20120094978
    Abstract: Compositions, kits and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof comprising alcaftadine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 4, 2011
    Publication date: April 19, 2012
    Inventors: Jagdish Parasrampuria, Avner Ingerman, Frans Janssens, Anton Megens
  • OCULAR ALLERGY TREATMENTS
    Publication number: 20080051385
    Abstract: Compositions, kits and methods for the treatment or prevention of ocular allergies and inflammation and the symptoms thereof comprising alcaftadine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 26, 2007
    Publication date: February 28, 2008
    Inventors: Jagdish Parasrampuria, Avner Ingerman, Frans Janssens, Anton Megens